ADAM12 and preeclampsia: Goetzinger et al. [14] demonstrated that at 11-14 weeks gestation, ADAM12, PAPP-A, and uterine artery Doppler in combination with maternal characteristics identified 50%, 48%, and 52% of patients who developed preeclampsia, respectively.